Qiagen NV - Company Profile

Powered by

All the data and insights you need on Qiagen NV in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Qiagen NV Strategy Report

  • Understand Qiagen NV position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Qiagen NV: Overview

Select Item

Related keylists

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA, and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and also through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

 Gain a 360-degree view of Qiagen NV and make more informed decisions for your business Gain a 360-degree view of Qiagen NV and make more informed decisions for your business Find out more
Headquarters Netherlands
Address Hulsterweg 82, Venlo, 5912PL
Website www.qiagen.com
Telephone 31 77 3556600
No of Employees 6,100
Industry Medical Equipment
Ticker Symbol & Exchange QIA (ETR)
Revenue (2022) $2.1B -4.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -17.4% (2022 vs 2021)
Market Cap* $9.5B
Net Profit Margin (2022) XYZ -13.2% (2022 vs 2021)
* As of and is in US$
View Qiagen NV financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Qiagen NV premium industry data and analytics

130+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

80+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

2

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Qiagen NV (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Qiagen NV’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
- -
Sample Technologies: Laboratory and Genomic Services
Primary Sample Technology Consumables
XYZ
XYZ
XYZ
Understand Qiagen NV portfolio and identify potential areas for collaboration Understand Qiagen NV portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 New Products/Services In November, the company launched QIAcuity Mycoplasma Quant Kit, QIAcuity OneStep Advanced EG Kit, and QIAcuity mericon Food Testing Kits.
2023 New Products/Services In November, the company announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow.
2023 Contracts/Agreements In November, the company and Element Biosciences entered into a strategic partnership to offer comprehensive next-generation sequencing (NGS) workflows for the Element AVITI System.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Qiagen NV Roche Diagnostics International Ltd Hologic Inc 2invest AG MilliporeSigma
Headquarters Netherlands Switzerland United States of America Germany United States of America
City Venlo Rotkreuz Marlborough Heidelberg Burlington
State/Province - Zug Massachusetts Baden-Wurttemberg Massachusetts
No. of Employees 6,100 2,600 6,944 2 9,000
Entity Type Public Private Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Thierry Bernard Managing Director; Chief Executive Officer Senior Management 2020 58
Roland Sackers Managing Director; Chief Financial Officer Senior Management 2006 54
Lawrence A. Rosen Chairman Non Executive Board 2020 65
Dr. Jonathan Sheldon Senior Vice President - QIAGEN Digital Insights Business Area Senior Management 2018 -
Stephany Foster Head - Human Resources; Senior Vice President Senior Management 2019 -
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into Qiagen NV key executives to enhance your sales strategy Gain insight into Qiagen NV key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward